UBS has slapped an outsized price target on Micron, citing 'enhanced' long-term supply agreements driven by strong memory chip demand that should meaningfully boost earnings power. The stock is up ~19% today and just crossed a $1T market cap, creating a classic 'buy the news, fade the squeeze' setup as insider selling accelerates into the rip.
UBS has slapped an outsized price target on Micron, citing 'enhanced' long-term supply agreements driven by strong memory chip demand that should meaningfully boost earnings power.
Fade the MU post-catalyst squeeze — 54 insider sells in 30 days into a $1T valuation pop screams distribution, not accumulation.
A follow-on beat-and-raise quarterly print, or a second major broker upgrade validating the LTA thesis with hard revenue numbers, would invalidate the short and force a painful cover into momentum.
CoverageSource: MarketWatch · Published here TUE, MAY 26 · 12:15 PM ET · the only report in this recordHow this is decided →
MU is up 19%+ on a single analyst upgrade, hitting a $1T valuation that puts it alongside Eli Lilly and Berkshire — a rich comp for a cyclical chip name. The enrichment shows zero insider buys vs. 54 insider sells in the last 30 days, signaling that those with the best information are distributing into strength. While the UBS LTA thesis is real, consensus is already 17 Strong Buy / 32 Buy — there's limited room for further upgrades to drive incremental buying, and the outsized gap-up likely front-runs much of the good news.
The read above, as written. kept as written
2-3 weeks post-catalyst. Follow to be told when one lands.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →